News

TraceLink Inc., announced its Russia compliance solution, providing companies with the ability to meet requirements for serialization, traceability, and compliance reporting for all…
Read More...

Astellas Pharma Inc. and Quethera Limited announced that Astellas has acquired Quethera, a gene therapy company headquartered in the United Kingdom, that is focused on developing novel…
Read More...

Teneobio and Poseida Therapeutics announced a new research collaboration and licensing agreement to develop novel CAR-T therapies using Teneobio’s heavy chain only domain antibodies…
Read More...

Almac Discovery, a biopharmaceutical company focused on discovering and identifying innovative therapeutics for the treatment of cancer, and Elasmogen, an SME focused on the development…
Read More...

PaxVax announced that it has entered into a definitive agreement to be acquired by Emergent BioSolutions. PaxVax is majority owned by an affiliate of Cerberus Capital Management, a…
Read More...

Perrigo Company plc announced that its Board of Directors approved a plan to separate the Company's Prescription Pharmaceuticals (Rx) business following the Company's previously…
Read More...

The U.S. Food and Drug Administration issued new scientific recommendations aimed at encouraging more widespread innovation and development of novel medication-assisted treatment (MAT)…
Read More...

Regeneron Pharmaceuticals, Inc. and bluebird bio, Inc. announced a collaboration to apply their respective technology platforms to the discovery, development and commercialization of…
Read More...

Seattle Children’s has opened a chimeric antigen receptor (CAR) T-cell immunotherapy trial for children and young adults with relapsed or refractory non-central nervous system…
Read More...

OvaScienceSM and privately-held Millendo Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing novel treatments for orphan endocrine diseases, announced…
Read More...

Scancell Holdings plc, the developer of novel immunotherapies for the treatment of cancer, announces that it has extended its strategic research collaboration with the Rheumatology Unit…
Read More...

Apexigen, Inc., a clinical-stage biopharmaceutical company, announced the successful completion of its Series B and Series C financings in which it raised a total of $73 million. The…
Read More...

Sotera Health announced that it has acquired New Jersey-based Gibraltar Laboratories. This acquisition expands the U.S.-based analytical testing capabilities of Sotera Health’s Nelson…
Read More...

Ambys Medicines and Takeda Pharmaceutical Company Limited announced that they have entered into a partnership to support the advancement of the Ambys platform and pipeline. “We are…
Read More...

XcellBio, a proprietary provider of primary cell control technologies for immunotherapeutic solutions announced a collaboration with Carolina BioOncology Institute (CBI) to further…
Read More...

TraceLink Inc. announced that it has joined the Irish Medicines Verification Organization (IMVO) serialization pilot study and will support a number of hospitals, pharmacies and clinics…
Read More...

Tanner Pharma Group has announced the signing of a distribution agreement with Nephcentric LLC, a developer and marketer of evidence based therapeutic options for people with kidney…
Read More...

Synergy Pharmaceuticals Inc. announced that the company has entered into a license agreement with Luoxin Pharmaceutical Group Co., Ltd., Shandong (Luoxin) providing Luoxin exclusive…
Read More...

Array BioPharma Inc. announced it has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for encorafenib (BRAFTOVI), in combination with…
Read More...

Antares Pharma, Inc. announced that it has entered into an agreement with Pfizer Inc. to develop a combination drug device rescue pen. This rescue pen will utilize the Antares QuickShot…
Read More...